Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler et al. (Mon,) studied this question.

www.synapsesocial.com/papers/69da1feb0d540cafc58385ec — DOI: https://doi.org/10.1016/s0140-6736(21)00461-x

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Antimicrobial resistance in the age of COVID-19· 2020 · 96 citations
2. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19· 2020 · 1,405 citations
3. Macrolide Therapy in Respiratory Viral Infections· 2012 · 157 citations
4. RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial· 2020 · 4,952 citations
5. Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both· 2017 · 989 citations